Big effect
Anthocyanins produced a large, statistically significant drop in CRP over 24 weeks — but only in older adults at risk for dementia
This is among the first indexed studies on anthocyanins and inflammation, so the finding is promising but requires replication; the effect also did not extend to all cholesterol markers, narrowing the benefit.
C-reactive protein (CRP) is a blood marker of systemic inflammation, linked to heart disease and other conditions. In this 24-week randomized controlled trial, anthocyanin supplementation led to a large reduction in CRP levels, especially in people with higher baseline inflammation. However, the study focused on older adults at risk for dementia, and total cholesterol and HDL did not budge, so the overall impact on cardiovascular risk is unclear.
Where this fits in the evidence
This is among the first studies we've indexed on Anthocyanins for Reduced C-Reactive Protein Levels — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- n = 99
- 2025-05-02
- GeroScience
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.